News & HighlightsNews
Rockefeller grants commercial license for the development of new HIV drugs
The novel compounds are based on so-called broadly neutralizing antibodies, molecules that make rare people's immune systems capable of fighting HIV. They could potentially yield new treatment and prevention approaches benefitting people around the world, including in developing countries.
Neuron-like activity detected in an unforeseen place
Scientists have identified a particular type of skin cell that looks and behaves similar to a nerve cell, prompting new questions about the body's biggest organ.
Patient with unusually severe infection leads scientists to a rare type of immune deficiency
A rare genetic change may explain why some people die from cytomegalovirus, a stealth pathogen that is often asymptomatic.
Small containers inside cells might offer new targets for cancer treatment
For reasons that have long been unclear, cells stop dividing when the pH rises inside tiny cellular compartments called lysosomes. Now scientists have found an explanation for this phenomenon, with potential implications for drug development.
How decisions unfold in a zebrafish brain
Tracking neuronal activity in a zebrafish brain, researchers can predict when the fish will flip its tail and to which direction, left or right.
Scientists examine how a gut infection may produce chronic symptoms
For some unlucky people, a bout of intestinal distress like traveler’s diarrhea leads to irritable bowel syndrome. Recent discoveries have given scientists a better idea of how this happens, and potential leads for new treatments.
Insects on a diet, zombie neurons, and other memorable science stories of 2019
Rockefeller researchers accomplished a lot this year. We look back at 12 of the most exciting science stories of 2019.
A surprising new source of attention in the brain
Scientists find a new brain area in control of our attention skills, raising new questions in what has long been considered a settled scientific field.
New clues about why a universal flu vaccine is so elusive
To scientists' surprise, the immune system develops its response to each virus variant mostly from scratch, instead of building on what it has already learned.
Researchers discover a new mechanism in childhood kidney cancer
A problem in reader proteins that identify which gene is up for expression may cause normal cells to turn malignant during development.
View
View